PremiumThe FlyEli Lilly reports full FDA approval of Inluriyo combo for certain breast cancers2d agoLLY
PremiumCompany AnnouncementsLilly’s New FORAY: Vepugratinib Targets FGFR3-Driven Bladder Cancer2d agoLLY